KORU Medical Systems, Inc.
KRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.21 | 2.35 | 2.08 | 24.41 |
| FCF Yield | 0.01% | -0.30% | -0.58% | 0.56% |
| EV / EBITDA | -299.79 | -1,558.48 | -137.96 | -124.20 |
| Quality | ||||
| ROIC | -3.35% | -1.66% | -5.12% | -7.65% |
| Gross Margin | 60.22% | 63.52% | 62.75% | 62.94% |
| Cash Conversion Ratio | -0.08 | 2.23 | 0.20 | -0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.86% | 7.78% | 6.50% | 6.45% |
| Free Cash Flow Growth | 102.65% | 28.16% | -169.35% | 149.50% |
| Safety | ||||
| Net Debt / EBITDA | 8.94 | 44.47 | 6.18 | 4.06 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.94 | 0.94 | 1.09 | 1.17 |
| Cash Conversion Cycle | 102.96 | 113.99 | 90.30 | 92.77 |